Abstract
There has been increasing evidence and growing popularity of orthobiologic treatments, such as platelet-rich plasma, bone marrow aspirate concentrate, and microfragmented adipose tissue. However, real-world data, including patient-reported pain and function outcomes, remains sparse for these procedures. Thus, collecting patient-reported outcome measures is important to evaluate the safety and efficacy of these treatments and hopefully improve patient care. Patient reported outcome measures can systematically be collected through patient registries. This narrative review serves to describe the data collection platforms and registries that obtain patient-reported outcome measures on orthobiologic procedures and provide a discussion on the benefits and limitations of registries. An internet search of the list of orthopedic registries available was conducted, and registries that collect patient-reported outcome measures for orthobiologic procedures were identified. Additional information regarding these various registries was collected by directly contacting these vendors. Publications from these registries, including case series, observational studies, and annual reports, were also reviewed. Providing this review will inform clinicians of a digital tool that can increase the efficiency of collecting outcome measures for orthobiologics and aid physicians in choosing a data collection platform.
Keywords: Musculoskeletal Conditions, Orthobiologics, Outcomes Assessment/Measurement
Background
Randomized controlled trials (RCTs) are the “gold standard” for evaluating the safety and efficacy of new therapeutic agents and medical interventions. RCTs achieve internal validity by reducing bias and confounding factors through randomization and strict patient inclusion and exclusion criteria. However, this often comes at the expense of external validity (generalizability) [1]. In addition, RCTs generally require extended periods of data collection and can be costly to perform. Real-world data is gathered outside of the conventional clinical trial setting and includes data obtained from patient charts, laboratory reports, patient registries, surveys, and mobile health devices [2]. This data can complement evidence obtained from RCTs by providing information about the long-term safety and effectiveness of medical interventions in large populations in a more naturalistic setting as well as allowing stakeholders and health insurance companies to assess the risk-benefit and economic value of medical interventions [1–3]. This allows for a more time-efficient and cost-effective method of data collection that is likely more reflective of the true clinical situations in which these procedures are performed. One method to systematically collect real-world data is through a registry database.
A registry is an organized system designed to collect uniform data to evaluate specific patient reported outcome measures (PROMs) for a population defined by a particular disease, condition, or exposure and which serves scientific, clinical, or policy purposes. PROMs are validated questionnaires that allow patients to report on their own health directly without interpretation from a physician [4]. Commonly employed PROMs include generic or general health instruments, which aim to provide a measure of general health for any health state [5]. An example is the European Qualify of Life (EurQol) 5 dimension health outcome survey (EQ-5D), which provides measures in the dimensions of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression [4, 6]. The second main type of PROMs are specific instruments, which focus on a specific symptom, disease, organ, body region, or body function. These may also be designed to measure the effect of a specific intervention or treatment [5]. There are numerous body-specific PROMs that have been validated and widely used for orthopedic conditions, such as the Knee Injury and Osteoarthritis Outcome Score (KOOS) and Hip Outcome Score (HOS) [7–9].
The burden of musculoskeletal diseases is expected to increase in the near future. For example, it is estimated that the prevalence of self-reported, doctor-diagnosed arthritis is projected to increase from 47.8 million in 2005 to nearly 67 million by 2030, which is 25% of the adult population in the US. By 2030, 25 million or 9.3% of the US adult population is projected to report arthritis-attributable activity limitations [10]. Furthermore, healthcare costs continue to rise in the US. As of 2018, the total health expenditure in the US was $3.6 trillion, which was 17.7% of the US gross domestic product [11]. With increasing prevalence of musculoskeletal diseases and growing healthcare costs, there has been a trend towards value-based health care and the need to systematically collect data in the form of patient registries. Orthobiologic procedures, such as platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and microfragmented adipose tissue (MFAT), utilize biologically-derived substances to promote the healing of tissue for various orthopedic conditions [12, 13]. Various RCTs and case series have recently been published to help support their use, such as PRP for osteoarthritis of the knee and various tendinopathies [14–18]. There is less robust evidence for bone marrow and adipose tissue procedures. Although there is a lack of robust evidence for these procedures, they are becoming increasingly offered by physicians to treat various orthopedic conditions. PROMs collected through patient registries can help complement data from RCTs by evaluating the safety and efficacy of these orthobiologic treatments. Furthermore, data from PROMs could help demonstrate potential cost savings of orthobiologics as an alternative to current standards of care including surgery.
This article serves to provide an overview and comparison of the available registries that collect data on orthobiologic procedures, such as PRP, BMAC, MFAT, allografts, and scaffolds. The characteristics of registries that will be discussed includes services provided by the registry, such as follow-up personnel or automatic reminders, platforms that patients can complete PROMs, HIPAA compliance, and costs. By providing this information, medical providers can obtain a better understanding of the registries and services available to collect PROMs that could potentially be used in their clinical practices. For this review, an internet search of the list of orthopedic registries available was conducted, and registries that collect PROMs for orthobiologic procedures were identified. Additional information regarding these various registries was collected by directly contacting these vendors. Publications from these registries, including case series, observational studies, and annual reports, were also reviewed. This review also provides a discussion on the limitations and benefits of registries as well as proposes methods to overcome challenges of using registries. A summary of this review can be found in Fig. 1 below.
Fig. 1.

Summary of Review
Main Text
Registry systems
Orthopedic registry systems have mostly focused on joint replacements as well as other orthopedic surgical procedures. There are currently 31 members of the International Society of Arthroplasty Registries (ISAR), including Canada, Spain, Egypt, Germany, Switzerland, Sweden, India, Iran, Ireland, Italy, Japan, United Kingdom, Pakistan, Portugal, France, South Africa, Australia, Denmark, Netherlands, Finland, Lithuania, New Zealand, Norway, Romania, and Slovakia [19]. Several US national registries have also been developed, including the American Joint Replacement Registry (AJRR), Function and Outcomes Research for Comparative Effectiveness in Total Joint Replacement (FORCE-TJR), the Kaiser Permanente National Total Joint Replacement Registry (TJRR), the Veterans Affairs and American College of Surgeons National Surgical Quality Improvement Programs (NSQIPs), and the National Trauma Data Bank (NTDB) [20]. ArthritisPower is another patient registry that was funded through a Patient-Centered Outcomes Research Institute Award and jointly developed by the non-profit Global Healthy Living Foundation (GHLF), CreakyJoints arthritis patient community, and rheumatology researchers at the University of Alabama at Birmingham (UAB). It focuses on rheumatoid conditions, such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis and has published in journals, such as Arthritis Research & Therapy. However, it tracks response to medications, such as methotrexate, rather than orthobiologic procedures [21, 22]. The following data collection platforms and registries will be focused on those that collect outcomes for orthobiologic procedures. A summary of these platforms and registries is provided in Table 1 and Table 2.
Table 1.
Summary of Orthobiologics and PROMs
| Registry/Data Collection Platform | Orthobiologic Procedures | Patient Reported Outcome Measures Used | HIPAA Compliant | |
|---|---|---|---|---|
| Oberd – Regenerative Orthobiologics Registry (ROR) |
A2M Amnion Matrix Allograft Fibrin Matrix Cord Allograft Plasma Concentrate Platelet Lysate PPP PRP Stem Cells |
Global Health Measures |
Adverse events EQ-50 NASS Satisfaction Index NPRS PROMIS (PROMIS 10 or CAT) SANE VR-12 |
Yes |
| Upper Extremity |
ASES Standardized Shoulder Assessment DASH quickDASH OSS WOSI |
|||
| Hip | HOOS, HOOS, Jr. | |||
| Knee |
KOOS, KOOS Jr. MARS PEDI-IKDC |
|||
| Foot and Ankle |
FAAM FADI |
|||
| Spine |
ODI NDI |
|||
| Oberd – AO Global Data Registry |
Allografts Scaffolds |
Global Health Measures |
PROMIS Short Form v1.0: Pain Interference 6b PROMIS Short Form v2.0: Physical Function 10a PROMIS Global Health SANE Visual Analog Scale |
Yes |
| Upper Extremity |
ASES Shoulder Assessment QuickDASH PROMIS Short Form V2.0: Upper Extremity 7a |
|||
| Hip | HOOS Jr. | |||
| Knee | KOOS Jr. | |||
| Foot and Ankle | FAAM | |||
| Spine |
NDI ODI |
|||
| Code Technology |
Allografts BMAC MFAT PRP Scaffolds |
Global Health Measures |
EQ-5D PROMIS Global 10 SF-36 VR-12 |
Yes |
| Upper Extremity |
ASES Shoulder Score DASH OSS PENN Shoulder Score SPADI UCLA Shoulder Score WOSI |
|||
| Hip |
AAOS Hip & Knee Score Harris Hip Score Hip Outcome Score HOOS, HOOS Jr. Oxford Hip Score |
|||
| Knee |
IKDC KOOS, KOOS Jr. Knee Society Score Lysholm Knee Scoring System MARS Oxford Knee Score WOMAC |
|||
| Foot and Ankle |
AOFAS FAAM |
|||
| Spine |
NDI ODI |
|||
| DataBiologics |
A2M BMAC MFAT Plasma Lysate PPP PRP Prolotherapy Shock Wave Therapy |
Global Health Measures |
Adverse Events NPRS PHQ-4 |
Yes |
| Upper Extremity | QuickDASH | |||
| Hip | HOOS Jr. | |||
| Knee | KOOS Jr. | |||
| Foot and Ankle |
FAAM VISA-A |
|||
| Spine |
NDI ODI |
|||
| InCytes |
Allografts BMAC Exosomes MFAT PRP Scaffolds Wharton’s Jelly |
Global Health Measures |
EQ-5D NPRS SF-12 SF-36 PROMIS VAS |
Yes |
| Upper Extremity |
DASH QuickDASH PRTEE WORC, Short WORC WOSI |
|||
| Hip |
HOOS, HOOS Jr. iHOT-12 WOMAC |
|||
| Knee |
IKDC KOOS, KOOS Jr. Lysholm Knee Scoring Scale MOCART TAS VISA-P WOMAC |
|||
| Foot and Ankle |
FAAM FADI FFI MFPDI VISA-A |
|||
| Spine |
NDI ODI, ODI - Modified |
|||
| OutcomeMD |
Allografts BMAC MFAT PRP Scaffolds |
Global Health Measures | PROMIS | Yes |
| Upper Extremity |
ASES Shoulder Score IOF Wrist Fracture QuickDASH |
|||
| Hip |
HOOS Jr. mHHS |
|||
| Knee | KOOS Jr. | |||
| Foot and Ankle |
ATRS FAAm FFI-R |
|||
| Spine |
NDI ODI |
|||
| Amplitude Clinical Outcomes – International Cartilage Regeneration and Joint Preservation Society (ICRS) |
Allografts Autologous anti-inflammatory injections BMAC MFAT PRP Scaffolds Stem Cell Amniotic-Based Injections |
Global Health Measures | EQ-5D | Yes |
| Knee |
KOOS Kujala Anterior Knee Pain Scale |
|||
| Arthrex - Surgical Outcomes System |
Allografts BMAC MFAT PRP Scaffolds |
Global Health Measures |
PROMIS-10 SANE VAS VR-12 |
Yes |
| Upper Extremity |
ASES-Elbow Score ASES Shoulder Score bMHQ CTS-6 KJOC Shoulder and Elbow Score Oxford Shoulder Score Penn Shoulder Score QuickDASH SST WORC WOOS WOSI |
|||
| Hip |
iHOT-12 mHHS NAHS Oxford Hip Score VHS |
|||
| Knee |
IKDC Knee Society Score Lysholm Knee Scoring System Knee Society Score KOOS, KOOS Jr. MARS MOCART Oxford Knee Score TAS |
|||
| Foot and Ankle |
AOFAS FAAM FFI-R MOCART |
|||
| Spine |
NDI ODI |
|||
| Ortech |
Allografts BMAC MFAT PRP Scaffolds |
Global Health Measures |
EQ-50 PROMIS 10 or CAT SANE VR-12 |
Yes |
| Upper Extremity |
ASES Shoulder Score DASH QuickDASH Oxford Shoulder Score WOSI |
|||
| Hip | HOOS, HOOS Jr. | |||
| Knee |
Pedi-IKDC KOOS, KOOS Jr. MARS |
|||
| Foot and Ankle |
FAAM FADI |
|||
| Spine |
NDI ODI |
|||
| PatientIQ |
BMAC PRP |
Global Health Measures |
EQ-50 PROMIS (PROMIS 10 or CAT) SANE VR-12 |
|
| Upper Extremity |
ASES Standardized Shoulder Assessment DASH quickDASH OSS WOSI |
|||
| Hip | HOOS, HOOS, Jr. | |||
| Knee |
KOOS, KOOS Jr. MARS PEDI-IKDC |
|||
| Foot and Ankle |
FAAM FADI |
|||
| DADOS | N/A | N/A | N/A | Yes |
| EUROSPINE – Spine Tango |
Bone grafts Bone Morphogenetic Proteins Scaffolds |
Global Health Measures |
EQ-3D SF-36 |
Yes – European Equivalent |
| Spine |
COMI-Back NDI ODI SRS-30 |
|||
Table 2.
Summary of Registry Features and Costs
| Registry/Data Collection Platform | Reminder Types | Compatible Devices | Costs | Partnerships & Sponsorships |
|---|---|---|---|---|
| Oberd – Regenerative Orthobiologics Registry (ROR) |
Text Phone |
Mobile Devices Tablets Personal Computers |
$300 per provider per month | ROR |
| Oberd – AO Global Data Registry |
Text |
Mobile Devices Tablets Personal Computers |
N/A | AAOS, AJRR, ASES, AO Foundation |
| Code Technology |
Text Phone |
Mobile Devices Tablets Personal Computers |
Per provider and per procedure pricing models available | Over 27 organizations, including AAOS, AJRR, NASS, CJRR, MARCQI, Moon ACL Registry |
| DataBiologics |
Text |
Mobile Devices Tablets Personal Computers |
$1500 per year | TOBI |
| InCytes |
Text |
Mobile Devices Tablets Personal Computers |
Annual model: $3000 per year for up to 5 users and 100 cases overall; $5–10 per additional case Monthly model: $35 per month per account |
|
| OutcomeMD |
Text Phone |
Mobile Devices Tablets Personal Computers |
$95 per provider per month | ICHOM |
| Amplitude Clinical Outcomes – International Cartilage Regeneration and Joint Preservation Society (ICRS) |
Text |
Mobile Devices Tablets Personal Computers |
$850 per provider per year | British Society for Surgery of the Hand, British Spine Registry, National Ligament Registry, ICRS |
| Arthrex - Surgical Outcomes System |
Mobile Devices Tablets Personal Computers |
$200 per provider per month Free with membership to American Orthopedic Society for Sports Medicine, Irish Shoulder and Elbow Society, American Shoulder and Elbow Surgeons, Arthroscopy Association of North America, and Eastern Orthopedic Association |
AANA, ASES, AOSSM, EOA | |
| Ortech |
Text |
Mobile Devices Tablets Personal Computers |
$6000 per provider for the first year $3000 per provider per year after |
CJRR, AJRR, MARCQI, NASS, Alberta Arthroplasty Database, Nova Scotia Health Authority Joint Registry |
| PatientIQ |
Text |
Mobile Devices Tablets Personal Computers |
N/A | AAOS Registry Program |
| DADOS |
Mobile Devices Tablets Personal Computers |
N/A | ||
| EUROSPINE – Spine Tango |
Text |
Mobile Devices Tablets Personal Computers |
Free to any EUROSPINE member | EUROSPINE |
Except for the InCytes data collection platform, all the other platforms highlighted in this review are partnered or sponsored by national or international registries. For example, the Oberd software has been used by the American Academy of Orthopaedic Surgeons (AAOS), American Joint Replacement Registry (AJRR), and American Shoulder and Elbow Surgeons (ASES). A summary of these partnerships can be found in Table 2. Overall, most of these registries have primarily collected data on orthopedic surgeries rather than orthobiologic treatments. However, there are some platforms that have a specific focus on the collection of PROMs for orthobiologic procedures. Oberd was utilized to create the Regenerative Orthobiologics Registry (ROR) [23, 24]. DataBiologics was recently endorsed as the official outcomes software for The Orthobiologic Institute (TOBI) [25, 26]. InCytes was created with a focus on collecting data for orthobiologic procedures [27]. Amplitude Clinical Outcomes is the software that powers the International Cartilage Regeneration and Joint Preservation Society (ICRS), which is another registry that focuses on orthobiologics [28, 29].
All the data collection platforms can be used to record the diagnosis for the treatment, the type of orthobiologic procedure performed, company and product name of the orthobiologic system, and where the treatment was performed. Besides the Spine Tango registry which only collects data for treatments of spine diseases and the ICRS which only collects data for knee pathologies, all the platforms collect PROMs for treatments across different parts of the body. A summary of the PROMs used for specific joints for each registry can be found in Table 1 [24, 25, 27–38]. Most of the data collection platforms have pre-set follow-up periods for sending PROMs, such as 3-months, 6-months, 9-months, one year, and two years. The Code Technology, InCytes, OutcomeMD, and Ortech platforms also allow clinicians to create customizable follow-up periods according to the organization’s needs.
Another important consideration in the type of PROMs utilized is response burden. A Cochrane review by Edwards et al. concluded that questionnaire length has a substantial impact on non-response rates. Amongst 56 trials, the odds of response increased by more than half using shorter postal questionnaires (OR 1.64, 95% 1.43–1.87). Only two trials involving electronic questionnaires were included in this same Cochrane review, but the odds increased by over a half when using shorter questionnaires (OR 1.73, 95% CI 1.40 to 2.13). However, this review noted that although shorter questionnaires were found to minimize non-response, it may be at the cost of a reduction of accuracy of the measurement process [39]. Thus, shortening questionnaires may not be an option unless if there have been studies to validate the abridged PROM. Examples of validated shortened versions of PROMs that these data collection platforms utilize include the QuickDASH, HOOS Jr., and KOOS Jr. [24, 25, 27–38]. Furthermore, the Patient Reported Outcome Measurement Information System (PROMIS) is a tool that can reduce response burden while maintaining validity of its measures. PROMIS utilizes computer-adaptive tests (CAT) where computer assessment software can deliver a brief and targeted sequence of items to an individual based on his or her previous item response. A typical PROMIS CAT can involve four to eight items and take about one to two minutes to complete while maintaining validity [40]. Data collection platforms that utilize PROMIS CAT include ROR, AO Global Data Registry, Code Technology, InCytes, OutcomeMD, Surgical Outcomes System, Ortech, and PatientIQ [27, 30–34, 38].
There are additional measures that can be taken to improve response rates. Pre-operative participation in PROM surveys had a significant positive association with participation at 3 months (OR 3.34, 95% CI 2.76–4.04) and at 1-year (OR 15.46, 95% CI 12.16–19.67) [41]. Compared to paper forms, electronic and Web-based methods of PROM collection has also shown to be more effective and has led to higher completion rates [42, 43]. Other solutions that also improved post-treatment survey completion included an electronic dashboard to track patients who did not complete their questionnaires and re-sending surveys, providing a paper version, and calling the patient to follow-up [44]. All the data collection platforms included in this review emphasize collecting pre-treatment PROMs. Email and text reminders are also utilized by all the data collection platforms, except for Arthrex which does not have text messaging reminders. ROR, Code Technology, and OutcomeMD also offer phone call reminders to patients. Furthermore, these registries are all web-based platforms where patients can complete PROMs on different devices, such as smartphones, tablets, and personal computers. Through these registries, clinicians will also have access to dashboards to track completion rates of PROMs. Some platforms, such as Code Technology, also have account managers who help to keep track of PROM completion rates [24, 25, 27–38].
Data privacy can also be a concern to both providers and patients. All the registries described in this review are HIPAA compliant or follow similar regulations based on their country of origin. These registries also utilize strict security protocols to ensure that patient data is protected. Costs of the data collection platform is another important factor that clinicians may consider. A summary of costs can be found in Table 2. However, pricing may vary depending on different factors, including choice of pricing models, licensing fees, specific needs and size of the institution, and additional features. Pricing information for certain data collection platforms were also not publicly disclosed and required an onboarding demonstration. Additionally, InCytes charged a fee per additional case after a maximum of 100 cases were reached. Code Technology also offered either a per provider or per procedure payment model. Fees per procedure or case could cause a potential selection bias when recruiting patients into the registry. Both the Surgical Outcomes System and Spine Tango registries can be utilized for free with membership to certain medical societies or groups [24, 25, 27–38].
Discussion
The literature on the use of orthobiologics has been mixed. Some recent RCTs and case series have helped to support the use of orthobiologic treatments [14–18]. For example, PRP was shown to be superior to hyaluronic acid or saline solution in the treatment of mild to moderate knee osteoarthritis [16]. However, other studies found that PRP did not provide a superior clinical improvement compared with hyaluronic acid [45, 46]. Study design could contribute to these mixed results, such as lack of standardization and characterization of the orthobiologic used in the study. Additionally, many of these trials contain small sample sizes, short duration of follow-up, and large costs and resources to perform [14–18]. Due to these limitations of RCTs, literature regarding adverse events and long-term follow up of orthobiologic treatments is lacking [47]. Registry data can be collected quickly and efficiently to help supplement the existing literature. Additionally, long-term outcomes of large patient populations can be collected through patient registries to capture rare and serious adverse events of orthobiologics that may not be detected during RCTs that are limited in time and sample size [48]. Currently, there is also a lack of literature on how the characteristics of the orthobiologic procedure can affect treatment, such as the volume or constituents of the injected material [47]. Patient registries could also be used to help fill this gap of knowledge.
The data collection platforms in this review gather important information, such as diagnosis, type of orthobiologic procedure performed, company and product name of the orthobiologic system, and where the treatment was performed [24, 25, 27–38]. However, clinicians should provide feedback to these data collection platforms to allow more specific parameters of the treatment to be entered into the platforms, such as volume of injectate and concentration of cellular components. All the patient registries in this review provide data analysis and outcome reports based on diagnoses and treatments. Having outcomes data on the specific parameters of treatments could help clinicians determine their efficacy and support decision making on how to best optimize orthobiologic procedures. Furthermore, long-term outcomes data collected through patient registries could help facilitate communication regarding the treatment course and prognosis of orthobiologics [49]. Finally, patient registry data can also be used to help determine the cost-effectiveness of orthobiologics [1].
Overall, the data collection platforms discussed in this review can help clinicians collect and monitor outcome measures. These platforms provide a system and interface that allows clinicians to easily collect data from patients without having to develop and design their own software, thus saving clinicians resources on time and money. Additionally, these platforms have an onboarding process that provides training in optimizing the use of the software as well training staff on best use practices in implementing a patient registry. By automating patient reminders to complete patient questionnaires, clinicians and their staff would not need to dedicate as much effort on patient follow-up. Furthermore, these platforms can be used as an effective feedback tool by providing data analysis and outcome reports to allow clinicians to make choices on how to improve and change treatment protocols based on their specific patient populations.
Review limitations
One disadvantage of registry data is lack of a control group. Thus, it is important to utilize patient registries to supplement data and optimize orthobiologic treatments that have been supported through RCTs. Additionally, there is concern of non-response bias with patient registries [50]. However, as previously discussed, all the data collection platforms in this review utilize various measures to increase response rates, including being internet-based platforms, collecting pre-treatment PROMs, automated patient reminders, and utilizing shorter questionnaires to reduce response burden [24, 25, 27–38]. Although all the patient registries in this review provide data analyses and reports, such as graphs with trends of the data, the patient registries in this review are not subjected to obligatory third-party checks or independent audits [51]. Thus, the data could be subject to random and systematic errors [52].
A limitation of this review is that it might not be possible to have identified all orthopedic registries. Although a robust search was attempted, registries that collect PROMs for orthobiologic procedures may have been missed as new platforms are continuing to be developed and started. Additionally, information regarding registry systems could be limited to only what is available publicly online. Attempts were made to directly contact the vendors discussed in this review. However, some companies were unable to be contacted. Other companies required a demonstration or onboarding process prior to disclosing specific information, such as pricing. Information regarding costs to utilize these registry systems is also limited as pricing depends on each institution’s needs, such as size of the institution, additional features offered, licensing fees, and other variables.
Future perspective
There are currently various orthopedic surgery registries available to clinicians. These registries also collect data on orthobiologic treatments but is not the main objective of these patient registries. However, patient registries specific to the collection of outcomes related to orthobiologic procedures are quite limited and include ROR, ICRS, DataBiologics, and InCytes. Furthermore, orthobiologic-specific patient registries have published sparse data mostly in the form of annual reports. According to The ICRS Patient Registry Annual Report 2020, no complications were documented following injection with orthobiologic treatments [29]. In the 2021 Outcomes Report for DataBiologics, meaningful reduction in pain within 12-months was found in 73, 70, and 61% of patients with knee osteoarthritis following treatment with PRP, adipose tissue therapy, and BMAC respectively. This report concluded that their outcomes data demonstrated potential effectiveness of PRP and adipose tissue based treatments for knee osteoarthritis [53]. Ultimately, the continued use and support of these patient registries is needed to allow for the growth of more outcomes data of orthobiologic procedures. With more outcomes data, the cost-effectiveness of orthobiologics can be determined. By using registry data to perform cost-benefit analyses, orthobiologic procedures could hopefully be proven to be the standard of care for specific indications and accepted by medical insurers.
Conclusions
Orthobiologic procedures are becoming more frequently performed clinically although there are concerns regarding their safety, clinical efficacy, and limited available evidence. Collection of PROMs can provide data on pain and function outcomes as well as elucidate the long-term safety, effectiveness, and potential cost savings of orthobiologic procedures. Various data collection platforms and registries have been described and compared in this review. Each platform offers different services to facilitate in data collection and vary in pricing. Clinicians have different goals when considering which registry to adopt into their practice. Furthermore, many clinicians have busy practices with limited resources or capabilities to independently employ a database registry in their practices. Thus, there appears to be a need for affordable and easy to use database registries specifically for the collection of outcomes for orthobiologic procedures. Providing this comparison will hopefully aid physicians in choosing a platform to collect PROMs.
Acknowledgements
Luke Malanga, Andrew Ward, and Yash Kulkarni all helped to correspond with representatives from the registries and data collection platforms to obtain additional information.
Abbreviations
- A2M
Alpha-2 Macroglobulin
- AANA
Arthroscopy Association of North America
- AAOS
American Academy of Orthopaedic Surgeons
- AJRR
American Joint Replacement Registry
- AOFAS
American Orthopedic Foot and Ankle Score
- AOSSM
American Orthopedic Society for Sports Medicine
- ASES
American Shoulder and Elbow Surgeons
- ATRS
Achilles Tendon Total Rupture Score
- BMAC
Bone Marrow Aspirate Concentrate
- bMHQ
Brief Michigan Hand Outcome Questionnaire
- CAT
Computer Adaptive Test
- CJRR
California Joint Replacement Registry
- COMI-Back
Core Outcome Measures Index for the Back
- CTS-6
6-Item Carpal Tunnel Symptoms Scale
- DASH
Disabilities of the Arm, Shoulder, and Hand
- EOA
Eastern Orthopedic Association
- EQ
European Quality of Life
- EurQol
European Quality of Life
- FAAM
Foot and Ankle Ability Measure
- FADI
Foot and Ankle Disability Index
- FFI-R
Foot Function Index Revised
- FORCE-TJR
Function and Outcomes Research for Comparative Effectiveness in Total Joint Replacement
- GHLF
Global Healthy Living Foundation
- HOOS
Hip Disability and Osteoarthritis Outcome Score
- ICHOM
International Consortium of Health Outcome Measures
- ICRS
International Cartilage Regeneration and Joint Preservation Society
- iHOT-12
International Hip Outcome Tool 12-Item
- IKDC
International Knee Documentation Committee
- IOF
International Osteoporosis Foundation
- ISAR
International Society of Arthroplasty Registries
- KJOC
Kerlan-Jobe Orthopaedic Clinic
- KOOS
Knee Injury and Osteoarthritis Outcome Score
- MARCQI
Michigan Arthroplasty Registry Collaborative Quality Initiative
- MARS
Marx Activity Rating Scale
- MFAT
Microfragmented Adipose Tissue
- MFPDI
Manchester Foot and Pain Disability Index
- mHHS
Modified Harris Hip Score
- MOCART
Magnetic Resonance Observation of Cartilage Repair Tissue
- NAHS
Non-Arthritic Hip Score
- NASS
North American Spine Society
- NDI
Neck Disability Index
- NIH
National Institutes of Health
- NPRS
Numeric Pain Rating Scale
- NSQIPs
National Surgical Quality Improvement Programs
- NTDB
National Trauma Data Bank
- ODI
Oswestry Disability Index
- OSS
Oxford Shoulder Score
- Patient Reported Outcome Measures
PROMs
- Pedi-IKDC
Pediatric International Knee Documentation Committee Subjective Knee Form
- PHQ-4
Patient Health Questionnaire-4
- PPP
platelet-poor plasma
- PROMIS
Patient-Reported Outcomes Measurement Information System
- PRP
platelet-rich plasma
- PRTEE
Patient-Related Tennis Elbow Evaluation
- RCT
Randomized Control Trial
- ROR
Regenerative Orthobiologics Registry
- RWS
Randall Woolcott Services
- SANE
Single Assessment Numeric Evaluation
- SF-36
36-Item Short Form Survey
- SOS
Surgical Outcomes System
- SPADI
Shoulder Pain and Disability Index
- SRS-30
Scoliosis Research Society 30-Item
- SST
Simple Shoulder Test
- TAS
Tegner Activity Scale
- TJRR
Total Joint Replacement Registry
- UAB
University of Alabama at Birmingham
- VAS
Visual Analog Score
- VHS
Vail Hip Score
- VISA-A
Victorian Institute of Sports Assessment – Achilles
- VISA-P
Victorian Institute of Sports Assessment – Patellar Tendinopathy
- VR-12
Veterans RAND 12
- WOMAC
Western Ontario and McMaster Universities Osteoarthritis Index
- WOOS
Western Ontario Osteoarthritis Shoulder Index
- WORC
Western Ontario Rotator Cuff Index
- WOSI
Western Ontario Shoulder Instability Index
Authors’ contributions
CM: Conception of work; acquisition and interpretation of information; drafting of manuscript; review and approval of final manuscript. GM: Conception of work; critical revision of manuscript; review and approval of final manuscript.
Funding
The Orthoregeneration Network (ON) Foundation awarded the authors a literature grant to support publication costs for a review on clinical registries in orthopedic practice and their coverage of regenerative techniques. DataBiologics did not provide any funding or financial support for the publication of this article.
Availability of data and materials
Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study. Not applicable.
Declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing Interests
Dr. Gerard Malanga is a Founder and partner of DataBiologics.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Blonde L, Khunti K, Harris SB, Meizinger C, Skolnik NS. Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician. Adv Ther. 2018;35(11):1763–1774. doi: 10.1007/s12325-018-0805-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Swift B, Jain L, White C, Chandrasekaran V, Bhandari A, Hughes DA, et al. Innovation at the Intersection of Clinical Trials and Real-World Data Science to Advance Patient Care. Clin Transl Sci. 2018;11(5):450–460. doi: 10.1111/cts.12559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Barnish MS, Turner S. The value of pragmatic and observational studies in health care and public health. Pragmat Obs Res. 2017;8:49–55. doi: 10.2147/POR.S137701. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Fidai MS, Saltzman BM, Meta F, Lizzio VA, Stephens JP, Bozic KJ, et al. Patient-Reported Outcomes Measurement Information System and Legacy Patient-Reported Outcome Measures in the Field of Orthopaedics: A Systematic Review. Arthroscopy. 2018;34(2):605–614. doi: 10.1016/j.arthro.2017.07.030. [DOI] [PubMed] [Google Scholar]
- 5.Rolfson O, Eresian Chenok K, Bohm E, Lubbeke A, Denissen G, Dunn J, et al. Patient-reported outcome measures in arthroplasty registries. Acta Orthop. 2016;87(Suppl 1):3–8. doi: 10.1080/17453674.2016.1181815. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.EQ-5D Instruments | About EQ-5D: EuroQol Group; [Available from: https://euroqol.org/eq-5d-instruments/. Accessed 20 Sep 2021.
- 7.Collins NJ, Prinsen CA, Christensen R, Bartels EM, Terwee CB, Roos EM. Knee Injury and Osteoarthritis Outcome Score (KOOS): systematic review and meta-analysis of measurement properties. Osteoarthr Cartil. 2016;24(8):1317–1329. doi: 10.1016/j.joca.2016.03.010. [DOI] [PubMed] [Google Scholar]
- 8.Martin RL, Kelly BT, Philippon MJ. Evidence of validity for the hip outcome score. Arthroscopy. 2006;22(12):1304–1311. doi: 10.1016/j.arthro.2006.07.027. [DOI] [PubMed] [Google Scholar]
- 9.Wilson I, Bohm E, Lubbeke A, Lyman S, Overgaard S, Rolfson O, et al. Orthopaedic registries with patient-reported outcome measures. EFORT Open Rev. 2019;4(6):357–367. doi: 10.1302/2058-5241.4.180080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hootman JM, Helmick CG. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum. 2006;54(1):226–229. doi: 10.1002/art.21562. [DOI] [PubMed] [Google Scholar]
- 11.Health Expenditures Center for Disease Control and Prevention [updated May 7, 2021. Available from: https://www.cdc.gov/nchs/fastats/health-expenditures.htm.
- 12.Crane DM, Oliver KS, Bayes MC. Orthobiologics and Knee Osteoarthritis: A Recent Literature Review, Treatment Algorithm, and Pathophysiology Discussion. Phys Med Rehabil Clin N Am. 2016;27(4):985–1002. doi: 10.1016/j.pmr.2016.07.004. [DOI] [PubMed] [Google Scholar]
- 13.Rodeo SA. Biologic Approaches in Sports Medicine:Potential, Perils, and Paths Forward. Am J Sports Med. 2016;44(7):1657–1659. doi: 10.1177/0363546516655130. [DOI] [PubMed] [Google Scholar]
- 14.Fitzpatrick J, Bulsara M, Zheng MH. The Effectiveness of Platelet-Rich Plasma in the Treatment of Tendinopathy: A Meta-analysis of Randomized Controlled Clinical Trials. Am J Sports Med. 2017;45(1):226–233. doi: 10.1177/0363546516643716. [DOI] [PubMed] [Google Scholar]
- 15.Houck DA, Kraeutler MJ, Thornton LB, McCarty EC, Bravman JT. Treatment of Lateral Epicondylitis With Autologous Blood, Platelet-Rich Plasma, or Corticosteroid Injections: A Systematic Review of Overlapping Meta-analyses. Orthop J Sports Med. 2019;7(3):2325967119831052. doi: 10.1177/2325967119831052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Lin KY, Yang CC, Hsu CJ, Yeh ML, Renn JH. Intra-articular Injection of Platelet-Rich Plasma Is Superior to Hyaluronic Acid or Saline Solution in the Treatment of Mild to Moderate Knee Osteoarthritis: A Randomized, Double-Blind, Triple-Parallel, Placebo-Controlled Clinical Trial. Arthroscopy. 2019;35(1):106–117. doi: 10.1016/j.arthro.2018.06.035. [DOI] [PubMed] [Google Scholar]
- 17.Lisi C, Perotti C, Scudeller L, Sammarchi L, Dametti F, Musella V, et al. Treatment of knee osteoarthritis: platelet-derived growth factors vs. hyaluronic acid. A randomized controlled trial. Clin Rehabil. 2018;32(3):330–339. doi: 10.1177/0269215517724193. [DOI] [PubMed] [Google Scholar]
- 18.Louis ML, Magalon J, Jouve E, Bornet CE, Mattei JC, Chagnaud C, et al. Growth Factors Levels Determine Efficacy of Platelets Rich Plasma Injection in Knee Osteoarthritis: A Randomized Double Blind Noninferiority Trial Compared With Viscosupplementation. Arthroscopy. 2018;34(5):1530–40.e2. doi: 10.1016/j.arthro.2017.11.035. [DOI] [PubMed] [Google Scholar]
- 19.Members: International Society of Arthroplasty Registries; [Available from: https://www.isarhome.org/members. Accessed 8 Aug 2021.
- 20.Cook CS, Smith PA. Update on Internet-Based Orthopedic Registries. Am J Orthop (Belle Mead NJ) 2017;46(6):284–289. [PubMed] [Google Scholar]
- 21.ArthritisPower [Available from: https://arthritispower.creakyjoints.org/. 8 Aug 2021.
- 22.Nowell WB, Gavigan K, Kannowski CL, Cai Z, Hunter T, Venkatachalam S, et al. Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower. Arthritis Res Ther. 2021;23(1):53. doi: 10.1186/s13075-021-02430-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Keeran L. Regnerative Orthobiologics Regsitry Success Story - Growing and Credentialing the Use of Orthobiologics OBERD2018 [Available from: https://www.oberd.com/insights/success-story-ror. Accessed Aug 2021.
- 24.McWilliams B, Helm P. Regenerative Orthobiologics Registry Data Collection and Reporting Webinar Regen Health Solutions [Available from: https://register.gotowebinar.com/register/4006341488261522435. Accessed Aug 2021.
- 25.DataBiologics [Available from: https://www.databiologics.com/. Accessed Aug 2021.
- 26.DataBiologics. TOBI Network Names DataBiologics its Official Outcomes Platform 2021 [Available from: https://medium.com/@info_74107/tobi-networks-names-databiologics-its-official-outcomes-platform-10d1d7160c94. Accessed Aug 2021.
- 27.inCytes™ [Available from: https://incytesapp.com/. Accessed Aug 2021.
- 28.Amplitude Clinical Outcomes [Available from: https://amplitude-clinical.com/. Accessed Aug 2021.
- 29.Asplin L, Conley C, McNicholas M. ICRS Patient Registry Annual Report 2020. International Cartilage Regeneration & Joint Preservation Society. [DOI] [PMC free article] [PubMed]
- 30.Oberd [Available from: https://www.oberd.com/prestigious-registries/. Accessed Aug 2021.
- 31.Code Technology [Available from: https://www.codetechnology.com/. Accessed Aug 2021.
- 32.OutcomeMD [Available from: https://www.outcomemd.com/#. Accessed Aug 2021.
- 33.Surgical Outcomes System [Available from: https://surgicaloutcomesystem.com/. Accessed Aug 2021.
- 34.Ortech Systems [Available from: https://ortechsystems.com/. Accessed Aug 2021.
- 35.DADOS Project [Available from: https://www.dadosproject.com/. Accessed Aug 2021.
- 36.EUROSPINE Spine Tango: EUROSPINE; [Available from: https://www.eurospine.org/spine-tango.htm. Accessed Aug 2021.
- 37.AO Global Data AO Foundation [Available from: https://www.aoglobaldata.com/. Accessed Aug 2021.
- 38.PatientIQ [Available from: https://www.patientiq.io/. Accessed Aug 2021.
- 39.Edwards PJ, Roberts I, Clarke MJ, Diguiseppi C, Wentz R, Kwan I, et al. Methods to increase response to postal and electronic questionnaires. Cochrane Database Syst Rev. 2009;2009(3):Mr000008. [DOI] [PMC free article] [PubMed]
- 40.Broderick JE, DeWitt EM, Rothrock N, Crane PK, Forrest CB. Advances in Patient-Reported Outcomes: The NIH PROMIS(®) Measures. EGEMS (Wash DC) 2013;1(1):1015. doi: 10.13063/2327-9214.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Patel J, Lee JH, Li Z, SooHoo NF, Bozic K, Huddleston JI. Predictors of Low Patient-Reported Outcomes Response Rates in the California Joint Replacement Registry. J Arthroplast. 2015;30(12):2071–2075. doi: 10.1016/j.arth.2015.06.029. [DOI] [PubMed] [Google Scholar]
- 42.Schamber EM, Takemoto SK, Chenok KE, Bozic KJ. Barriers to Completion of Patient Reported Outcome Measures. J Arthroplast. 2013;28(9):1449–1453. doi: 10.1016/j.arth.2013.06.025. [DOI] [PubMed] [Google Scholar]
- 43.Viveen J, Prkic A, The B. Koenraadt KL, Eygendaal D. Effect of introducing an online system on the follow-up of elbow arthroplasty. World J Orthop. 2016;7(12):826–831. doi: 10.5312/wjo.v7.i12.826. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Chenok K, Teleki S, SooHoo NF, Huddleston J, 3rd, Bozic KJ. Collecting Patient-Reported Outcomes: Lessons from the California Joint Replacement Registry. EGEMS (Wash DC) 2015;3(1):1196. doi: 10.13063/2327-9214.1196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Cole BJ, Karas V, Hussey K, Pilz K, Fortier LA. Hyaluronic Acid Versus Platelet-Rich Plasma: A Prospective, Double-Blind Randomized Controlled Trial Comparing Clinical Outcomes and Effects on Intra-articular Biology for the Treatment of Knee Osteoarthritis. Am J Sports Med. 2017;45(2):339–346. doi: 10.1177/0363546516665809. [DOI] [PubMed] [Google Scholar]
- 46.Di Martino A, Di Matteo B, Papio T, Tentoni F, Selleri F, Cenacchi A, et al. Platelet-Rich Plasma Versus Hyaluronic Acid Injections for the Treatment of Knee Osteoarthritis: Results at 5 Years of a Double-Blind, Randomized Controlled Trial. Am J Sports Med. 2019;47(2):347–354. doi: 10.1177/0363546518814532. [DOI] [PubMed] [Google Scholar]
- 47.Marenah M, Li J, Kumar A, Murrell W. Quality assurance and adverse event management in regenerative medicine for knee osteoarthritis: Current concepts. J Clin Orthop Trauma. 2019;10(1):53–58. doi: 10.1016/j.jcot.2018.09.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Choinière M, Ware MA, Pagé MG, Lacasse A, Lanctôt H, Beaudet N, et al. Development and Implementation of a Registry of Patients Attending Multidisciplinary Pain Treatment Clinics: The Quebec Pain Registry. Pain Res Manag. 2017;2017:8123812. doi: 10.1155/2017/8123812. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Gagnier JJ. Patient reported outcomes in orthopaedics. J Orthop Res. 2017;35(10):2098–2108. doi: 10.1002/jor.23604. [DOI] [PubMed] [Google Scholar]
- 50.Centeno CJ, Al-Sayegh H, Bashir J, Goodyear S, Freeman MD. A prospective multi-site registry study of a specific protocol of autologous bone marrow concentrate for the treatment of shoulder rotator cuff tears and osteoarthritis. J Pain Res. 2015;8:269–276. doi: 10.2147/JPR.S80872. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Tevaearai H, Carrel T. Clinical registries: yes, but then appropriately! Eur J Cardiothorac Surg. 2013;44(4):614–615. doi: 10.1093/ejcts/ezt083. [DOI] [PubMed] [Google Scholar]
- 52.Bautista MP, Bonilla GA, Mieth KW, Llinás AM, Rodríguez F, Cárdenas LL. Data Quality in Institutional Arthroplasty Registries: Description of a Model of Validation and Report of Preliminary Results. J Arthroplast. 2017;32(7):2065–2069. doi: 10.1016/j.arth.2017.02.030. [DOI] [PubMed] [Google Scholar]
- 53.Guevarra-Fernandez J, Potpally N. An Overview of Regenerative Treatments for Orthopedic Conditions: 2021 Outcomes Report. 2021. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study. Not applicable.
